Literature DB >> 21296960

Mycobacterium tuberculosis can utilize heme as an iron source.

Christopher M Jones1, Michael Niederweis.   

Abstract

Most iron in mammals is found within the heme prosthetic group. Consequently, many bacterial pathogens possess heme acquisition systems to utilize iron from the host. Here, we demonstrate that Mycobacterium tuberculosis can utilize heme as an iron source, suggesting that M. tuberculosis possesses a yet-unknown heme acquisition system.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21296960      PMCID： PMC3067660          DOI： 10.1128/JB.01312-10

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  30 in total

Review 1.  Bacterial solutions to the iron-supply problem.

Authors:  V Braun; H Killmann
Journal:  Trends Biochem Sci       Date:  1999-03       Impact factor: 13.807

2.  The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.

Authors:  J J De Voss; K Rutter; B G Schroeder; H Su; Y Zhu; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Cloning and expression of a Serpula (Treponema) hyodysenteriae hemolysin gene.

Authors:  S Muir; M B Koopman; S J Libby; L A Joens; F Heffron; J G Kusters
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Transmembrane movement of heme.

Authors:  W R Light; J S Olson
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

Review 5.  The Lactobacillus anomaly: total iron abstinence.

Authors:  E D Weinberg
Journal:  Perspect Biol Med       Date:  1997       Impact factor: 1.416

6.  Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum.

Authors:  D J Dawson; F Jennis
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

7.  Isolation of a contact-dependent haemolysin from Mycobacterium tuberculosis.

Authors:  R G Deshpande; M B Khan; D A Bhat; R G Navalkar
Journal:  J Med Microbiol       Date:  1997-03       Impact factor: 2.472

8.  Most human isolates of Mycobacterium avium Mav-A and Mav-B are strong producers of hemolysin, a putative virulence factor.

Authors:  Laura Rindi; Daniela Bonanni; Nicoletta Lari; Carlo Garzelli
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Molecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: a non-conventional hemolysin and a ribosomal RNA methyl transferase.

Authors:  Aejazur Rahman; Saumya S Srivastava; Amita Sneh; Neesar Ahmed; Musti V Krishnasastry
Journal:  BMC Biochem       Date:  2010-09-20       Impact factor: 4.059

10.  Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae.

Authors:  B W Wren; R A Stabler; S S Das; P D Butcher; J A Mangan; J D Clarke; N Casali; T Parish; N G Stoker
Journal:  Microbiology       Date:  1998-05       Impact factor: 2.777
View more
  50 in total

1.  Characterization of heme ligation properties of Rv0203, a secreted heme binding protein involved in Mycobacterium tuberculosis heme uptake.

Authors:  Cedric P Owens; Jing Du; John H Dawson; Celia W Goulding
Journal:  Biochemistry       Date:  2012-02-08       Impact factor: 3.162

2.  Organ pathology in the absence of bacteria?

Authors:  Christopher M Jones; Michael Niederweis
Journal:  J Infect Dis       Date:  2013-11-17       Impact factor: 5.226

3.  Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.

Authors:  Curtis A Engelhart; Courtney C Aldrich
Journal:  J Org Chem       Date:  2013-07-12       Impact factor: 4.354

4.  Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteins.

Authors:  Heidi Contreras; Matthew S Joens; Lisa M McMath; Vincent P Le; Michael V Tullius; Jaqueline M Kimmey; Neda Bionghi; Marcus A Horwitz; James A J Fitzpatrick; Celia W Goulding
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

5.  A novel antimycobacterial compound acts as an intracellular iron chelator.

Authors:  Marte S Dragset; Giovanna Poce; Salvatore Alfonso; Teresita Padilla-Benavides; Thomas R Ioerger; Takushi Kaneko; James C Sacchettini; Mariangela Biava; Tanya Parish; José M Argüello; Magnus Steigedal; Eric J Rubin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 6.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

7.  Surface hydrolysis of sphingomyelin by the outer membrane protein Rv0888 supports replication of Mycobacterium tuberculosis in macrophages.

Authors:  Alexander Speer; Jim Sun; Olga Danilchanka; Virginia Meikle; Jennifer L Rowland; Kerstin Walter; Bradford R Buck; Mikhail Pavlenok; Christoph Hölscher; Sabine Ehrt; Michael Niederweis
Journal:  Mol Microbiol       Date:  2015-07-04       Impact factor: 3.501

8.  Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.

Authors:  Maher Y Abdalla; Barbara L Switzer; Christopher H Goss; Moira L Aitken; Pradeep K Singh; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

9.  PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA.

Authors:  Michael V Tullius; Susana Nava; Marcus A Horwitz
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

10.  Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis.

Authors:  Olivia Vergnolle; Hua Xu; JoAnn M Tufariello; Lorenza Favrot; Adel A Malek; William R Jacobs; John S Blanchard
Journal:  J Biol Chem       Date:  2016-08-26       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.